Sunil Sharma

Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India

Taufik Momin, Kevinkumar Kansagra, Hardik B. Patel et al. · EClinicalMedicine · 2021 · 183 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Smartphone app in self-management of chronic low back pain: a randomized controlled trial

Harvinder Singh Chhabra, Sunil Sharma, Shalini Verma · European Spine Journal · 2018 · 182 citations

Medicine, Physical Medicine, Pain Management +9

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

Xinxue Liu, Alasdair Munro, Shuo Feng et al. · Journal of Infection · 2022 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Deborah Wentworth, Andrew Phillips, Kathryn Shaw‐Saliba et al. · Annals of Internal Medicine · 2022 · 63 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15